This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...